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The epidermis is a self-renewing tissue that must
maintain a basal proliferative rate as well as respond to
various perturbing stimuli. Regulation of keratinocyte
proliferation involves diverse molecules, including
growth factors, ions, and hormones. We recently pro-
posed that a proteinase, urokinase-type plasminogen
activator (uPA) may be added to this list, based on
correlative evidence linking expression of uPA and
murine epidermal hyperproliferation. Here we report
that, during the first 3 d of life, the epidermis from
The epidermis, in its role as a multi-layered barrieragainst the external environment, is constantlyshedding terminally differentiated keratinocytes fromits surface. To compensate for this cellular loss, acontinuous supply of new keratinocytes must be
generated from the proliferative (i.e., basal) population that
resides along the dermal–epidermal junction. In unperturbed
adult human or murine epidermis, maintenance of tissue steady
state requires that only 2%–4% of interfollicular basal keratinocytes
be proliferating at any given time (Potten and Hendry, 1973;
Lavker and Sun, 1982); however, the percentage of proliferating
keratinocytes can rapidly increase to greater than 25% (Wilson
et al, 1994) in response to a variety of stimuli (e.g., wounding)
or disease states (e.g., psoriasis). Furthermore, epidermal morpho-
genesis that occurs during neonatal life requires a high rate of
keratinocyte proliferation (Wilson et al, 1994).
Studies into the regulation of keratinocyte proliferation have
implicated a diverse array of molecules, including cytokines,
growth factors, ions, and hormones (Eckert, 1989). Proteinases
represent another category of molecules that, although not
traditionally thought of as modulators of proliferation, should be
considered as potential candidates. The plasminogen activator
(PA) cascade is one such proteolytic system. Although the PA
cascade has been primarily studied for its roles in vascular
patency and tissue remodeling (Dano et al, 1985; Carmeliet and
Collen, 1995; Plow et al, 1995), there are a few reports that
link PA enzymes to positive regulation of cell proliferation
(Kirchheimer et al, 1988; De Petro et al, 1994; Reidy et al,
1996; Li et al, 1997). In murine skin in vivo, we recently found
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mice that bear a targeted deletion of the uPA gene
has a significantly lower proliferative rate than the
epidermis from wild-type mice. In contrast, prolifera-
tion in the matrix keratinocytes of the hair follicles
is not decreased in neonatal uPA–/– mice. Vertical
migration of keratinocytes during terminal differenti-
ation was not affected. We therefore conclude that
lack of uPA is associated with a decrease in epidermal
proliferation. J Invest Dermatol 112:240–244, 1999
that, in a wide range of epidermal hyperproliferative states, basal
keratinocytes consistently express urokinase-type PA (uPA) (Jensen
and Lavker, 1996). These data led us to propose two hypotheses:
(i) uPA may directly upregulate epidermal proliferation, e.g., by
activation of growth factor(s); or (ii) uPA may promote vertical
migration of basal keratinocytes into the suprabasal layers, thereby
aiding in tissue remodeling that must accompany epidermal
hyperproliferation.
One of the hyperproliferative states in which uPA is consistently
upregulated is neonatal mouse epidermis (Jensen and Lavker,
1996). The enhanced epidermal proliferative rate of the
neonate as compared with the adult is presumably necessary to
accommodate rapid growth of the animal. In this study we have
tested the role of uPA in this naturally occurring epidermal
hyperproliferative state using neonatal mice that bear a targeted
deletion of the uPA gene (Carmeliet et al, 1994). The data here
presented suggest that one of the functions of epidermal uPA is
to promote keratinocyte proliferation.
MATERIALS AND METHODS
Mice Derivation of uPA–/–, tPA–/–, and wild-type mice has been
described (Carmeliet et al, 1994). C57Bl/6 breeding pairs for use as
other controls were obtained from The Jackson Laboratory (Bar Harbor,
ME). For some experiments, uPA–/– mice on a C57Bl/6 background
were obtained from The Jackson Laboratory.
Quantitation of proliferation in epidermis in vivo Mice were
injected subcutaneously with bromo-deoxyuridine (BrdU; 50 µg per g
body weight) and euthanized by CO2 inhalation 90 min later. There
was no difference in body weight of uPA–/– and wild-type mice at
any age, in agreement with the normal fetal and neonatal development
of uPA–/– mice (Carmeliet et al, 1994). Skin biopsies were taken from
the nape of the neck and processed for 5 mm paraffin sections, which
were immunochemically stained with anti-BrdU antibody and alkaline
phosphatase-labeled secondary IgG (both from Boehringer, Indianapolis,
IN), followed by visualization with red substrate (Vector Laboratories,
Burlingame, CA; substrate #1). To determine labeling index of the
epidermis, at least 1000 total basal cells were counted and the percentage
of stained nuclei was calculated.
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Figure 1. Proliferative activity is
decreased in epidermis from uPA–/–
mice. At days 1 (a, b), 3 (c, d), and 5 (e,
f) of life, mice were injected subcutaneously
with BrdU and sacrificed 90 min later.
Skin biopsies were taken from the nape of
the neck. Paraffin sections were stained
with anti-BrdU antibody and alkaline
phosphatase-labeled secondary IgG,
followed by visualization with red substrate.
A greater number of BrdU-labeled basal
keratinocytes (arrowheads) is observed in the
epidermis (E) of wild-type (a, c) compared
with uPA–/– mice (b, d) at days 1 and 3
of life. By day 5 (e, f) of life, the number
of BrdU-labeled keratinocytes is similar in
wild-type (e) and uPA–/– (f) mice. HF,
hair follicle.
Table I. Epidermal proliferation rate is decreased in
neonatal uPA–/– micea
Proliferative labeling index
Post-natal day uPA–/– wild type tPA–/–
1 7.9b 6 1.3 (15) 13.0 6 2.4 (17) 13.7 6 3.1 (8)
3 10.7b 6 2.0 (15) 17.2 6 4.2 (17) 18.6 6 3.2 (7)
5 15.9 6 1.8 (8) 17.0 6 3.5 (10) 23.5 6 2.9 (4)
7 9.5 6 0.8 (5) 12.3 6 1.6 (3) 11.9 (1)
13 6.3 6 2.2 (2) 8.0 6 0.2 (2) 7.2 6 1.1 (5)
17 4.4 6 1.6 (4) 4.8 6 1.8 (6) 5.1 6 1.5 (4)
21 3.6 6 1.0 (2) 3.0 6 0.8 (3) 2.9 6 1.6 (4)
aEpidermal proliferative rates of mice at the indicated days of life were determined
using BrdU injection and immunostaining of skin biopsies, as described in Fig 1.
For quantification, at least 1000 total basal keratinocytes were counted and the
percentage of BrdU-positive cells was calculated (labeling index). The number of
animals analyzed for each time point is given in parenthesis and data shown are the
average 6 SD. For the wild-type values, mice with similar genetic backgrounds to
the uPA–/– mice and tPA–/– mice (hybrids of C56Bl/6 and 129 strains; Carmeliet
et al, 1994) as well as inbred C57Bl/6 mice were analyzed. No differences were
noted in any parameter in these wild-type strains and hence all wild-type values
were combined and averaged in this study. Similarly, five of the 15 uPA–/– analyzed
at postnatal day 3 had been back-crossed to a pure C56Bl/6 background (obtained
from The Jackson Laboratory); there was no significant difference in the labeling
index of the inbred versus the hybrid uPA–/– mice.
bProliferative indices of uPA–/– mice significantly different (p , 0.001 using the
student’s t test) from wild-type controls.
Quantitation of proliferation in hair follicles in vivo In the sections
stained with anti-BrdU antibody (as described immediately above), we
also analyzed those follicular matrices that were longitudinally sectioned
through the center of the follicular papilla. For image analysis, only
keratinocytes located below the widest diameter of the matrix (the
critical line of Auber) were included because this is the region of the
majority of proliferative activity in the follicle (Auber, 1950–1). We
quantitated the percentage area of this region of the follicle bulb that
was occupied with red reaction product using the spectral discrimination
feature of a Southern Microsystems computer-assisted image analysis
system.
Table II. Hair matrix keratinocyte proliferation is normal
in uPA–/– micea
% Stained area
Post-natal day uPA–/– wild type
1 52.0 6 4.0 55.9 6 8.6
3 61.0 6 5.0 60.0 6 7.6
aMice during the first and third postnatal day were injected with BrdU, and skin
biopsies were stained with anti-BrdU antibody, all as described in Fig 1. Hair follicle
proliferation was quantified by determining the percentage area of the hair follicle
matrix occupied by anti-BrdU-(red)-stained nuclei. Three to five mice were analyzed
for each time point. There was no significant difference between uPA–/–and wild-
type mice.
RESULTS AND DISCUSSION
Epidermal proliferation is decreased in uPA–/– mice
in vivo To test whether uPA modulates epidermal proliferation,
we compared the proliferative rate of epidermis from neonatal
uPA–/– and wild-type mice by determining the percentage of
basal cells that incorporated BrdU and thus were in the S phase
of the cell cycle during a single pulse labeling period (labeling
index). During the first postnatal day, the epidermal labeling
index of uPA–/– mice was 7.9% 6 1.3% compared with
13.0% 6 2.4% for wild-type mice (Fig 1a, b, Table I). This
was highly significant (p , 0.001), representing a 40% decrease
in proliferation. The difference in proliferative rate was maintained
through postnatal day 3; however, by postnatal day 5 the
epidermal proliferative rate of uPA–/– mice was not significantly
different from that of normal mice. Over the next 2 wk of
life, epidermal proliferation in both uPA–/– and wild-type mice
gradually and similarly declined, until reaching the normal adult
value of 2%–4% by day 21.
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Figure 2. Proliferation is normal in matrix keratinocytes of the hair
follicles in uPA–/– mice. Mice at 3 d of life were injected with BrdU
and skin biopsies were stained with anti-BrdU antibody, all as described
in Fig 1. The matrix portion of hair follicles from wild-type C57Bl/6
mice (a, b) and uPA–/– mice (c, d) showed comparable numbers of BrdU
(red) stained keratinocyte nuclei. fp; follicular papilla.
In normal murine epidermis, uPA is not the only PA activity
detectable; rather, another independent PA, known as tissue-type
(tPA) is also present (Jensen and Lavker, 1996). To determine if
loss of tPA had similar epidermal consequences to loss of uPA, we
quantificated the epidermal proliferative rate of mice with a targeted
deletion of tPA. In contrast to the results obtained with uPA–/– mice,
the epidermal proliferative rate of tPA–/– mice was indistinguishable
from the wild-type mice in animals of all ages (Table I).
These data thus demonstrate that lack of uPA is associated with a
transient inhibition of epidermal proliferation. Several, more indirect
studies have likewise suggested that uPA may promote proliferation
of a variety of cell types. For example, increased uPA mRNA and
activity have been correlated with ovarian follicle growth in the
mouse (Li et al, 1997) and with smooth muscle and endothelial cell
proliferation induced by arterial injury in the rat (Reidy et al, 1996).
Furthermore, exogenous uPA and/or tPA have been shown to pro-
mote proliferation in variety of cell types in culture (Kirchheimer
et al, 1989; De Petro et al, 1994); however, our present data constitute
the first in vivo evidence that lack of uPA can adversely affect cell
proliferation. The partial and transient nature of the defect argues
for redundant or compensatory mechanisms regulating epidermal
proliferation.
Hair follicle proliferation is not affected in uPA–/– mice
in vivo Theexperimentsdescribedabove also allowedus toexamine
hair follicle development in uPA–/– mice. The earliest stages of
murine hair follicle neogenesis are detectable late in fetal life as
a segregation and clustering of rapidly proliferating keratinocytes
(Wilson et al, 1994). A high level of proliferation is maintained as
these keratinocytes invaginate into the dermal stroma and form the
epithelial portion (matrix) of the follicular bulb. Proliferation con-
tinues for µ15 d after birth, resulting in the elaboration of a dense
coat of hair, essential for survival of the animal. uPA–/– and wild-
type mice revealed comparably strong incorporation of BrdU into
the matrix keratinocytes of the bulb, the site of the proliferative cells
that give rise to all portions of the hair shaft (Fig 2, Table II).
Consistent with these observations, hair development was clinically
normal in uPA–/– mice. It is generally accepted that the proliferative
populations of epidermal and follicular keratinocytes are highly
related in that they are derived from a common keratinocyte stem
cell (Cotsarelis et al, 1990; Sengal, 1990; Kamimura et al, 1997). In
light of these findings it is of particular interest that our present data
suggest a difference in the regulation of proliferation of these two
keratinocyte populations.
Epidermal transit time is not altered in uPA–/– mice
in vivo Because uPA has repeatedly been associated with cell migra-
tion (Grøndahl-Hansen et al, 1988; Rømer et al, 1991, 1994, 1996;
Kramer et al, 1995; Ando and Jensen, 1996; Bugge et al, 1996), we
questioned whether uPA might promote the vertical migration of
individual keratinocytes through the epidermis; such migration is
essential for maintenance of an orderly cellular arrangement within
the hyperproliferative epidermis.
To investigate this hypothesis, we performed ‘‘transit time’’
experiments (Fig 3) that allowed us to follow the fate of BrdU-
labeled cells with time. An entire litter of mice was injected with
BrdU on the first day of life, and then 1–2 animals were euthanized
at days 1, 2, 3, 5, and 7 after injection. One day after BrdU
injection, nearly all labeled keratinocytes were located in the basal
layer (Fig 3a). Vertical movement of keratinocytes was indicated
by the detection of labeled cells in the suprabasal layers (Fig 3b,
arrows). Such movement out of the basal layer and into the suprabasal
layer was detected by day 2 (Fig 3e). Significant numbers of labeled
cells were detected in the granular layers beginning at day 3 (Fig 2c,
f), and by day 7 most labeled cells were lost from the living layers.
This time course for the vertical migration of keratinocytes was
comparable for both wild-type and uPA–/– mice (Fig 3d–g),
indicating that uPA does not play an essential role in this type of
tissue remodeling.
Summary and hypotheses In this study we have shown that
the epidermal keratinocytes of uPA–/– mice exhibit a significant
decrease in proliferation rate during the first 3 d of life. The
decrease is transient, however, as proliferation has normalized by
day 5 of life and then gradually declines, with a time course similar
to wild-type mice, to the very low rates characteristic of adult
epidermis. These observations are consistent with our previously
published findings on the epidermis from normal mice, in which
uPA mRNA and activity are high at birth and then gradually
decline (Jensen and Lavker, 1996). In contrast to uPA–/– mice,
epidermis from tPA–/– mice exhibits normal proliferative rates at
all ages.
The mechanism by which uPA may promote epidermal prolifera-
tion is currently unclear. One possibility is that uPA binds to and
stimulates the uPA receptor, which has signal transduction capability
(Dear and Medcalf, 1998; Konakova et al, 1998). Another reasonable
hypothesis involves cleavage of hepatocyte growth factor. This
factor is a mitogen for keratinocytes (Kan et al, 1991; Matsumoto
et al, 1991) that is produced by dermal fibroblasts (Rubin et al,
1991) and thus is available for epidermal action. Furthermore,
hepatocyte growth factor is directly cleaved to its active form by
uPA (Naldini et al, 1992; Mars et al, 1996). The possible involvement
of the uPA receptor or HGF in uPA-mediated epidermal prolifera-
tion remains to be tested. None the less, our data illustrate that the
PA system may very well have physiologic roles that are independent
of fibrinolysis.
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Figure 3. The keratinocyte transit time is similar between wild-type and uPA–/– mice. All mice from four litters (two wild type and two
uPA–/– ) were injected subcutaneously with BrdU on the first day of life. Because the nucleotide is rapidly cleared, only those cells in S phase of the
cell cycle at the time of injection are labeled and the fate of the labeled cells can be followed with time. One to two mice per time point from each
litter were sacrificed at 1, 2, 3, 5, and 7 d post-injection, and skin was processed for immunostaining as described in Fig 1. One day after BrdU injection,
most BrdU-labeled keratinocytes are restricted to the basal layer (a; arrowheads). In subsequent days (b), BrdU-labeled keratinocytes are detected in both
supra-basal (arrows) as well as basal (arrowhead) positions. The BrdU-labeled keratinocytes continue to move upwards and are finally detected in the granular
layer (c; arrow), prior to nuclear degeneration, terminal differentiation, and eventual sloughing from the surface. At each day the number of BrdU-positive
cells present in the basal (d), suprabasal (e), and granular (f) layers was counted per 403 field, and these data were plotted for wild-type (u, solid line)
and uPA–/– mice (e, dotted line). Each point is the average of counts from three to four mice 6 SD. The curves are very similar for wild-type and
uPA–/– mice, indicating no significant difference in transit time. In (g), the percentage of the total number of BrdU-labeled cells that is present in each
layer is shown for all time points; there is no significant difference between uPA–/– and wild-type mice at any time.
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